Bilaketaren emaitzak - James P. Rizzi
- Erakusten 1 - 7 emaitzak -- 7
-
1
-
2
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models nork Hyejin Cho, Xinlin Du, James P. Rizzi, Ella Liberzon, Abhishek A. Chakraborty, Wenhua Gao, Ingrid Carvo, Sabina Signoretti, Richard K. Bruick, John A. Josey, Eli M. Wallace, William G. Kaelin
Argitaratua 2016Artigo -
3
Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins nork Jayashree Aiyar, Jane M. Withka, James P. Rizzi, David H. Singleton, Glenn C. Andrews, Lu‐Yin Lin, James G. Boyd, Douglas C. Hanson, Mariella Simon, B Dethlefs, Chao-lin Lee, James E. Hall, George A. Gutman, K. George Chandy
Argitaratua 1995Artigo -
4
3-[(1<i>S</i>,2<i>S</i>,3<i>R</i>)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Tre... nork Rui Xu, Keshi Wang, James P. Rizzi, Heli Huang, Jonas Grina, Stephen T. Schlachter, Bin Wang, Paul M. Wehn, Hanbiao Yang, Darryl D. Dixon, Robert Czerwiński, Xinlin Du, Emily L. Ged, Guangzhou Han, Huiling Tan, Tai‐Tong Wong, Shanhai Xie, John A. Josey, Eli M. Wallace
Argitaratua 2019Artigo -
5
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma nork Eli M. Wallace, James P. Rizzi, Guangzhou Han, Paul M. Wehn, Zhaodan Cao, Xinlin Du, Tzuling Cheng, Robert Czerwiński, Darryl D. Dixon, Barry S. Goggin, Jonas Grina, Megan M. Halfmann, Melissa A. Maddie, Sarah R. Olive, Stephen T. Schlachter, Huiling Tan, Bin Wang, Keshi Wang, Shanhai Xie, Rui Xu, Hanbiao Yang, John A. Josey
Argitaratua 2016Artigo -
6
Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia nork Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris, Matthias Bartenstein, Nandini Ramachandra, Orsi Giricz, Vineeth Sukrithan, George Nwankwo, Samira Shahnaz, Tushar D. Bhagat, Sanchari Bhattacharyya, Amer Assal, Aditi Shastri, Shanisha Gordon-Mitchell, Andrea Pellagatti, Jacqueline Boultwood, Carolina Schinke, Yiting Yu, Chandan Guha, James P. Rizzi, Jennifer Garrus, Suzy A. Brown, Lance Wollenberg, Grant Hogeland, Dale Wright, Mark Munson, Mareli Rodriguez, Stefan Groß, David Chantry, Yiyu Zou, Leonidas C. Platanias, Laurence E. Burgess, Kith Pradhan, Ulrich Steidl, Amit Verma
Argitaratua 2016Artigo -
7
Targeting renal cell carcinoma with a HIF-2 antagonist nork Wenfang Chen, Haley Hill, Alana Christie, Min Soo Kim, Eboni Holloman, Andrea Pavía-Jiménez, Farrah Homayoun, Yuanqing Ma, Nirav Patel, Paul C. Yell, Guiyang Hao, Qurratulain Yousuf, Allison Joyce, Iván Pedrosa, Heather Geiger, He Zhang, Jenny H. Chang, Kevin H. Gardner, Richard K. Bruick, Catherine Reeves, Tae Hyun Hwang, Kevin D. Courtney, Eugene P. Frenkel, Xiankai Sun, Naseem J. Zojwalla, Tai‐Tong Wong, James P. Rizzi, Eli M. Wallace, John A. Josey, Yang Xie, Xian‐Jin Xie, Payal Kapur, Renée M. McKay, James Brugarolas
Argitaratua 2016Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Biology
Gene
Medicine
Biochemistry
Cancer research
Angiogenesis
Cancer
Chemistry
Clear cell renal cell carcinoma
Internal medicine
Renal cell carcinoma
Transcription factor
Biophysics
Cell
Cell culture
Genetics
Hypoxia-inducible factors
In vivo
Mathematics
Neuroscience
Oncology
Potassium channel
Vestibular system
Vestibule
Angiopoietin receptor
Bone marrow
CD34
Cancer cell
Carcinogenesis
Cell biology